Navigation Links
Master gene SRC-3 enables breast cancer growth, invasion
Date:2/12/2010

HOUSTON - (Feb. 12, 2009) The master gene called SRC-3 (steroid receptor coactivator 3) not only enhances estrogen-dependent growth of cancer cells by activating and encouraging the transcription of a genetic message into a protein, it also sends a signal to the cell membrane to promote cell motility or movement a key element of cancer spread or metastasis, said Baylor College of Medicine (www.bcm.edu) researchers and collaborators in a report that appears in the current issue of the journal Molecular Cell.

The finding not only uncovers a new activity for SRC-3 at the cell's periphery, it also clears up a mystery about how the message that tells a cell to invade gets from the epidermal growth factor receptor (EGFR) to the activating enzyme called FAK (focal adhesion kinase) found on the cell's membrane, said Dr. Bert O'Malley (http://www.bcm.edu/mcb/?PMID=7694), chair of molecular and cellular biology (http://www.bcm.edu/mcb/?PMID=0) at BCM and the report's senior author.

"Two-thirds of breast cancers over express the gene SRC-3," said O'Malley, who is the 2008 National Medal of Science recipient. "The work represented in this paper shows that a coactivator gene (SRC-3) can produce an alternative form of its coactivator protein a shorter form that is missing the part of the protein that keeps it in the nucleus. With that portion (called an exon) gone, it leaves the nucleus and goes into the cytoplasm (or general area of the cell) and travels to the membrane," he said.

"At the membrane, the enzyme PAK1 (p21-activted kinase 1) phosphorylates (attaches a phosphate molecule that activates the coactivator) SRC-3, allowing it to function at the membrane," said O'Malley, responsible for identifying the first receptor coactivator and advancing the field in general.

The finding explains how the epidermal growth factor receptor at the membrane gets a signal to the enzyme that tells the cell to move and ultimately grow, allowing the cancer to invade surrounding tissue, said O'Malley.

"Now we have a final picture as to why epidermal growth factor receptor and the estrogen receptor are the most dangerous combination of molecules overproduced in breast cancer," said O'Malley. "When they are both over functioning, people die quickly and are resistant to therapy."


'/>"/>

Contact: Dipali Pathak
pathak@bcm.edu
713-798-4710
Baylor College of Medicine
Source:Eurekalert

Related biology news :

1. Master regulator found for regenerating nerve fibers in live animals
2. New research network at McMaster aims to build a better eye
3. Master gene that switches on disease-fighting cells identified by scientists
4. Suppressing cancer with a master control gene
5. McMaster researchers discover new mode of how diseases evolve
6. Master gene plays key role in blood sugar levels
7. New book helps medical students master clinical skills
8. New master switch found in the brain that regulates appetite and reproduction
9. McMaster University engineering professor receives Humboldt Research Award
10. Master Lock(R) smartTOUCH(TM) Garage Door Opener to be Featured on Hispanic Network Radio Weekend Show
11. Bits of junk RNA aid master tumor-suppressor gene
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2017)... 20, 2017 PMD Healthcare announces the release ... Wellness Management System (WMS), a remote, real-time lung health ... PMD Healthcare is a Medical Device, Digital Health, and ... to creating innovative solutions that empower people to improve ... focus, PMD developed the first ever personal spirometer, Spiro ...
(Date:3/9/2017)... , March 9, 2017 4Dx has publicly ... Lung Imaging Workshop at the University of Pennsylvania. Founder ... to deliver the latest data to world leaders in ... brings together leaders at the forefront of the industry ... imaging. "The quality of the imaging ...
(Date:3/7/2017)... March 7, 2017   HireVue , the leading ... companies identify the best talent, faster, today announced the ... Officer (CSO) and Diana Kucer as Chief ... seasoned executive team poised to drive continued growth in ... a year of record bookings in 2017. ...
Breaking Biology News(10 mins):
(Date:3/28/2017)...  Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage ... for metabolic and endocrine disorders, today announced that its ... deliver a corporate presentation at H.C. Wainwright & Co.,s ... April 3, 2017 at the St. Regis Hotel in ... are as follows: H.C. Wainwright ...
(Date:3/28/2017)... NEW YORK , March 28, 2017 /PRNewswire/ ... a highly volatile and unpredictable sector due to ... space. Markets served include medical, agricultural, environmental, and ... these four stocks: Portola Pharmaceuticals Inc. (NASDAQ: PTLA), ... OCRX), and Ocular Therapeutix Inc. (NASDAQ: ...
(Date:3/27/2017)... March 27, 2017 Roka Bioscience, Inc. (NASDAQ: ROKA), ... for the detection of foodborne pathogens,  today announced that ... Company Spring 2017 Convention on March 29 at 9:50am ET. ... Marquis. About Roka Bioscience ... Roka Bioscience is ...
(Date:3/27/2017)... March 27, 2017  The global market for ... according to a new report from Kalorama Information.  ... is performed to evaluate disease progression, monitor drug ... other reasons.  The healthcare market research firm,s report, ... provides an overview of the medical laboratory industry ...
Breaking Biology Technology: